EVH
Evolent Health Inc
3.60$
+2.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 23.9% | 25.5% | 25.3% | 21.0% | 21.7% | 23.9% | 27.4% | 22.8% | 23.2% | 26.7% | 26.7% | 31.0% | |
| 6.9% | 7.2% | 6.2% | 4.1% | 3.9% | 4.1% | 9.3% | 6.1% | 4.8% | 8.0% | 8.8% | 5.9% | |
| 6.9% | 7.2% | 6.2% | 4.1% | 3.9% | 4.1% | 9.3% | 6.1% | 4.8% | 8.0% | 8.8% | 5.9% | |
| 14.8% | 16.7% | 16.2% | 15.1% | 16.3% | 16.3% | 16.2% | 14.6% | 15.8% | 17.0% | 16.7% | 22.8% | |
| 0.9% | 0.0% | – | – | – | – | – | – | – | – | – | – | |
| 3.6% | – | – | – | 3.3% | 3.1% | 3.0% | 3.4% | 3.5% | 4.5% | – | – | |
| 41.9% | 41.7% | 42.2% | 45.1% | 45.5% | 44.7% | 42.9% | 46.2% | 43.8% | 36.6% | 37.0% | 35.2% | |
| 29.1% | 28.1% | 27.7% | 28.7% | 27.9% | 26.7% | 25.2% | 26.5% | 31.1% | 30.8% | 30.3% | 28.1% | |
| 58.9% | 60.2% | 60.4% | 57.4% | 58.5% | 60.6% | 64.7% | 63.6% | 65.7% | 78.1% | 78.9% | 80.6% | |
| 23.0% | 25.2% | 24.9% | 19.5% | 20.9% | 28.1% | 27.9% | 22.6% | 17.5% | 20.3% | 20.3% | 25.0% | |
| 0.5% | 0.4% | 0.5% | 0.2% | 0.2% | 7.8% | 7.8% | 8.0% | 0.9% | 0.8% | 0.5% | 0.1% | |
| 1.9% | 1.8% | 2.9% | 1.6% | 2.0% | 3.8% | 2.2% | 2.8% | 2.9% | 3.1% | 3.4% | 2.0% | |
| 22.5% | 22.3% | 22.6% | 24.2% | 24.0% | 19.3% | 24.4% | 26.3% | 43.0% | 51.1% | 51.8% | 49.0% | |
| 41.1% | 39.8% | 39.6% | 42.6% | 41.5% | 39.4% | 35.3% | 36.4% | 34.3% | 21.9% | 21.1% | 19.4% | |
| -25.7% | -26.8% | -27.9% | -29.7% | -30.3% | -30.7% | -31.9% | -35.2% | -36.1% | -69.3% | -71.4% | -69.5% | |
| 4.2% | 4.2% | 4.3% | 4.6% | 4.6% | 4.5% | 4.3% | 4.7% | 4.6% | 6.0% | 6.0% | 5.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.